Simtra BioPharma Solutions

Video interview with Ray Guidotti, Chief Operating Officer, Simtra BioPharma Solutions

Talking Strategic Development with Simtra at DCAT

Simtra BioPharma Solutions is a premier contract development and manufacturing organization (CDMO) with more than 65 years of sterile injectable (SI) experience and a dedicated focus on providing a range of services from clinical development to commercial fill/finish. Learn more about:

Simtra’s new building in Halle that features a high-speed syringe line and vial line equipped with four lyophilizers and is expected to be GMP ready in 2024.

The new clinical line in Bloomington that will be ready to take on projects in the summer of 2025.

Construction of the new state-of-the-art building in Bloomington that will begin in the summer of 2024.

Videos

Ray Guidotti, Chief Operating Officer at Simtra BioPharma Solutions, talks about the company's strategic development and how it supports customers with a focus on excellence. 

Opportunities in sterile fill/finish available based on new capacities by Simtra BioPharma Solutions

Simtra BioPharma Solutions Announces Expansion Project and Unique Opportunities

Role of Simtra BioPharma Solutions in the sterile fill/finish arena

New capacities available through Simtra based on global expansion

Sterile fill/finish opportunities to deliver better care to patients

Sean Knight, Simtra BioPharma Solutions, reacts to the company's global expansion efforts and investment in sterile fill/finish.

Simtra BioPharma Solutions Reacts to Expansion and Unique Opportunities in the Industry

Introducing Simtra BioPharma Solutions

Franco Negron, CEO, Simtra BioPharma Solutions, discusses:

 Simtra BioPharma Solutions specializes in sterile injectables and offers manufacturing expertise to help pharmaceutical and biotechnology companies overcome the challenges associated with producing parenteral drug products. With over 65 years of experience, they bring a wealth of knowledge to the table, making them a valuable partner for clients in the industry.

An Integrated Approach to Project Management:

 Simtra adopts an integrated approach to project management, emphasizing close collaboration with clients, responsive customer service and sterile manufacturing technical expertise. Simtra values its relationships with pharmaceutical clients and strives to establish open, mutually beneficial partnerships. They emphasize close communication and collaboration with their clients, and they assemble highly skilled and experienced client teams dedicated to delivering on mutually agreed project commitments. This client-centric approach allows them to consistently deliver quality products on time and within budget, making them a trusted partner in the pharmaceutical and biotechnology industry.

Future Path for Simtra BioPharma Solutions: 

The future of Simtra at the reigns of Franco Negron and his unwavering commitment to innovation and desire to transform the biopharmaceutical industry. Simtra is positioned to become a powerful player within the industry.

Franco Negron, CEO, Simtra BioPharma Solutions, discusses the company's expertise in supporting the development and manufacture of sterile injectables, its integrated approach to project management, and his expectations regarding the company's future in the industry.

Simtra BioPharma Solutions

Articles